✦ LIBER ✦

410 POSTER Phase I pharmacodynamic (PD) and pharmacokinetic (PK) analysis of the sorafenib (S) and erlotinib (E) combination in patients with advanced solid tumors

✍ Scribed by C. Le Tourneau; I. Duran; E. Chen; L. Wang; M. Tsao; D. Hedley; N. Phan; T. Do; U. Metser; L. Siu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1247 POSTER Phase I, Pharmacokinetics (P

✍ M. Simonelli; P.A. Zucali; R. De Sanctis; E. Lorenzi; F. De Vincenzo; L. Rimassa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase I pharmacokinetic and pharmacodyna

✍ Simonelli, Matteo; Zucali, Paolo A.; Lorenzi, Elena; Rubino, Luca; De Vincenzo, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 585 KB

1455 POSTER Safety, pharmacokinetics (PK

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

706 POSTER A phase I dose escalation pha

✍ S. Chia; K. Chi; C. Kollmannsberger; K. Paton; K. Bhagat; S. D'Aloisio; A. Das-G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

599 Phase I and pharmacokinetic (PK) stu

✍ A. Ricart; S. Syed; D. Drolet; C. Quaratino-Baker; J. Horan; M. Rothenberg; A. T 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 144 KB

346 POSTER CBP501, a novel cell cycle G2

✍ M.S. Gordon; J.P. Eder; D.S. Mendelson; E. Wasserman; W. Sutherland; T. Kawabe; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB